Dipeptidyl peptidase IV inhibitors for the treatment of diabetes.
Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065, USA. ann_weber@merck.com
Ann E
AE
Weber
D000818:Animals; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000201:enzymology; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism*; D004353:Drug Evaluation, Preclinical; D006801:Humans; D011480:Protease Inhibitors / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D013329:Structure-Activity Relationship
D011480:Protease Inhibitors; D018819:Dipeptidyl Peptidase 4